Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018
Background The Nordic countries have comparable nationwide antibiotic resistance surveillance systems and individual antibiotic stewardship programmes. The aim of this study was to assess antibiotic resistance among major pathogens in relation to practice guidelines for hospital antibiotic treatment...
Published in: | Infectious Diseases |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | http://hdl.handle.net/10852/93124 http://urn.nb.no/URN:NBN:no-95715 https://doi.org/10.1080/23744235.2021.1910338 |
id |
ftoslouniv:oai:www.duo.uio.no:10852/93124 |
---|---|
record_format |
openpolar |
spelling |
ftoslouniv:oai:www.duo.uio.no:10852/93124 2023-05-15T16:47:17+02:00 Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018 Möller, Vidar Östholm-Balkhed, Åse Berild, Dag Fredriksson, Mats Gottfredsson, Magnus Holmbom, Martin Järvinen, Asko Kristjansson, Mar Rydell, Ulf Sönksen, Ute Wolff Kolmos, Hans Joern Hanberger, H 2022-02-17T18:45:08Z http://hdl.handle.net/10852/93124 http://urn.nb.no/URN:NBN:no-95715 https://doi.org/10.1080/23744235.2021.1910338 EN eng http://urn.nb.no/URN:NBN:no-95715 Möller, Vidar Östholm-Balkhed, Åse Berild, Dag Fredriksson, Mats Gottfredsson, Magnus Holmbom, Martin Järvinen, Asko Kristjansson, Mar Rydell, Ulf Sönksen, Ute Wolff Kolmos, Hans Joern Hanberger, H . Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018. Infectious Diseases. 2021, 53(8), 607-618 http://hdl.handle.net/10852/93124 2003051 info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Infectious Diseases&rft.volume=53&rft.spage=607&rft.date=2021 Infectious Diseases 53 8 607 618 https://doi.org/10.1080/23744235.2021.1910338 URN:NBN:no-95715 Fulltext https://www.duo.uio.no/bitstream/handle/10852/93124/1/M%25C3%25B6ller%2Bet%2Bal.pdf Attribution-NonCommercial-NoDerivatives 4.0 International https://creativecommons.org/licenses/by-nc-nd/4.0/ CC-BY-NC-ND 2374-4235 Journal article Tidsskriftartikkel Peer reviewed PublishedVersion 2022 ftoslouniv https://doi.org/10.1080/23744235.2021.1910338 2022-04-06T22:33:50Z Background The Nordic countries have comparable nationwide antibiotic resistance surveillance systems and individual antibiotic stewardship programmes. The aim of this study was to assess antibiotic resistance among major pathogens in relation to practice guidelines for hospital antibiotic treatment and antibiotic use in Nordic countries 2010–2018. Methods Antibiotic resistance among invasive isolates from 2010–2018 and aggregated antibiotic use were obtained from the European Centre for Disease Prevention and Control. Hospital practice guidelines were obtained from national or regional guidelines. Results Antibiotic resistance levels among Escherichia coli and Klebsiella pneumoniae were similar in all Nordic countries in 2018 and low compared to the European mean. Guidelines for acute pyelonephritis varied; 2nd generation cephalosporin (Finland), 3rd generation cephalosporins (Sweden, Norway), ampicillin with an aminoglycoside or aminoglycoside monotherapy (Denmark, Iceland and Norway). Corresponding guidelines for sepsis of unknown origin were 2nd (Finland) or 3rd (Sweden, Norway, Iceland) generation cephalosporins, carbapenems, (Sweden) combinations of penicillin with an aminoglycoside (Norway, Denmark), or piperacillin-tazobactam (all Nordic countries). Methicillin-resistant Staphylococcus aureus rates were 0–2% and empirical treatment with anti-MRSA antibiotics was not recommended in any country. Rates of penicillin non-susceptibility among Streptococcus pneumoniae were low (<10%) except in Finland and Iceland (<15%), but benzylpenicillin was recommended for community-acquired pneumonia in all countries. Conclusion Despite similar resistance rates among Enterobacteriaceae there were differences in practice guidelines for pyelonephritis and sepsis. National surveillance of antibiotic resistance can be used for comparison and optimization of guidelines and stewardship interventions to preserve the low levels of antibiotic resistance in Nordic countries. Article in Journal/Newspaper Iceland Universitet i Oslo: Digitale utgivelser ved UiO (DUO) Norway Infectious Diseases 53 8 607 618 |
institution |
Open Polar |
collection |
Universitet i Oslo: Digitale utgivelser ved UiO (DUO) |
op_collection_id |
ftoslouniv |
language |
English |
description |
Background The Nordic countries have comparable nationwide antibiotic resistance surveillance systems and individual antibiotic stewardship programmes. The aim of this study was to assess antibiotic resistance among major pathogens in relation to practice guidelines for hospital antibiotic treatment and antibiotic use in Nordic countries 2010–2018. Methods Antibiotic resistance among invasive isolates from 2010–2018 and aggregated antibiotic use were obtained from the European Centre for Disease Prevention and Control. Hospital practice guidelines were obtained from national or regional guidelines. Results Antibiotic resistance levels among Escherichia coli and Klebsiella pneumoniae were similar in all Nordic countries in 2018 and low compared to the European mean. Guidelines for acute pyelonephritis varied; 2nd generation cephalosporin (Finland), 3rd generation cephalosporins (Sweden, Norway), ampicillin with an aminoglycoside or aminoglycoside monotherapy (Denmark, Iceland and Norway). Corresponding guidelines for sepsis of unknown origin were 2nd (Finland) or 3rd (Sweden, Norway, Iceland) generation cephalosporins, carbapenems, (Sweden) combinations of penicillin with an aminoglycoside (Norway, Denmark), or piperacillin-tazobactam (all Nordic countries). Methicillin-resistant Staphylococcus aureus rates were 0–2% and empirical treatment with anti-MRSA antibiotics was not recommended in any country. Rates of penicillin non-susceptibility among Streptococcus pneumoniae were low (<10%) except in Finland and Iceland (<15%), but benzylpenicillin was recommended for community-acquired pneumonia in all countries. Conclusion Despite similar resistance rates among Enterobacteriaceae there were differences in practice guidelines for pyelonephritis and sepsis. National surveillance of antibiotic resistance can be used for comparison and optimization of guidelines and stewardship interventions to preserve the low levels of antibiotic resistance in Nordic countries. |
format |
Article in Journal/Newspaper |
author |
Möller, Vidar Östholm-Balkhed, Åse Berild, Dag Fredriksson, Mats Gottfredsson, Magnus Holmbom, Martin Järvinen, Asko Kristjansson, Mar Rydell, Ulf Sönksen, Ute Wolff Kolmos, Hans Joern Hanberger, H |
spellingShingle |
Möller, Vidar Östholm-Balkhed, Åse Berild, Dag Fredriksson, Mats Gottfredsson, Magnus Holmbom, Martin Järvinen, Asko Kristjansson, Mar Rydell, Ulf Sönksen, Ute Wolff Kolmos, Hans Joern Hanberger, H Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018 |
author_facet |
Möller, Vidar Östholm-Balkhed, Åse Berild, Dag Fredriksson, Mats Gottfredsson, Magnus Holmbom, Martin Järvinen, Asko Kristjansson, Mar Rydell, Ulf Sönksen, Ute Wolff Kolmos, Hans Joern Hanberger, H |
author_sort |
Möller, Vidar |
title |
Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018 |
title_short |
Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018 |
title_full |
Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018 |
title_fullStr |
Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018 |
title_full_unstemmed |
Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018 |
title_sort |
antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in nordic hospitals 2010–2018 |
publishDate |
2022 |
url |
http://hdl.handle.net/10852/93124 http://urn.nb.no/URN:NBN:no-95715 https://doi.org/10.1080/23744235.2021.1910338 |
geographic |
Norway |
geographic_facet |
Norway |
genre |
Iceland |
genre_facet |
Iceland |
op_source |
2374-4235 |
op_relation |
http://urn.nb.no/URN:NBN:no-95715 Möller, Vidar Östholm-Balkhed, Åse Berild, Dag Fredriksson, Mats Gottfredsson, Magnus Holmbom, Martin Järvinen, Asko Kristjansson, Mar Rydell, Ulf Sönksen, Ute Wolff Kolmos, Hans Joern Hanberger, H . Antibiotic resistance among major pathogens compared to hospital treatment guidelines and antibiotic use in Nordic hospitals 2010–2018. Infectious Diseases. 2021, 53(8), 607-618 http://hdl.handle.net/10852/93124 2003051 info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Infectious Diseases&rft.volume=53&rft.spage=607&rft.date=2021 Infectious Diseases 53 8 607 618 https://doi.org/10.1080/23744235.2021.1910338 URN:NBN:no-95715 Fulltext https://www.duo.uio.no/bitstream/handle/10852/93124/1/M%25C3%25B6ller%2Bet%2Bal.pdf |
op_rights |
Attribution-NonCommercial-NoDerivatives 4.0 International https://creativecommons.org/licenses/by-nc-nd/4.0/ |
op_rightsnorm |
CC-BY-NC-ND |
op_doi |
https://doi.org/10.1080/23744235.2021.1910338 |
container_title |
Infectious Diseases |
container_volume |
53 |
container_issue |
8 |
container_start_page |
607 |
op_container_end_page |
618 |
_version_ |
1766037379055878144 |